BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37651123)

  • 21. The Clinical and Pathological Effects of Serum C3 Level and Mesangial C3 Intensity in Patients with IgA Nephropathy.
    Hou X; Liang Y; Zhang W; Li R
    Anal Cell Pathol (Amst); 2024; 2024():8889306. PubMed ID: 38204800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
    Muda AO; Feriozzi S; Rahimi S; Faraggiana T
    J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
    Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collectin11 and Complement Activation in IgA Nephropathy.
    Wei M; Guo WY; Xu BY; Shi SF; Liu LJ; Zhou XJ; Lv JC; Zhu L; Zhang H
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1840-1850. PubMed ID: 34615657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.
    Kim SJ; Koo HM; Lim BJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Doh FM; Park JT; Yoo TH; Kang SW; Choi KH; Jeong HJ; Han SH
    PLoS One; 2012; 7(7):e40495. PubMed ID: 22792353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study.
    Stefan G; Stancu S; Zugravu A; Terinte-Balcan G
    Ren Fail; 2024 Dec; 46(1):2313179. PubMed ID: 38357771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese.
    Xie J; Kiryluk K; Li Y; Mladkova N; Zhu L; Hou P; Ren H; Wang W; Zhang H; Chen N; Gharavi AG
    J Am Soc Nephrol; 2016 Oct; 27(10):3187-3194. PubMed ID: 26940089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.
    Bellur SS; Troyanov S; Cook HT; Roberts IS;
    Nephrol Dial Transplant; 2011 Aug; 26(8):2533-6. PubMed ID: 21273233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
    Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
    Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesangial C4d Deposits in Early IgA Nephropathy.
    Segarra A; Romero K; Agraz I; Ramos N; Madrid A; Carnicer C; Jatem E; Vilalta R; Lara LE; Ostos E; Valtierra N; Jaramillo J; Arredondo KV; Ariceta G; Martinez C
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):258-264. PubMed ID: 29146701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and pathological features in IgA nephropathy with IgG deposition in the glomerular mesangial area].
    Xu XM; Zhu SS; Wang XH; Shao XF; Li B; Zhang Y; Liu Q; Li JM; Wang HL; Li YQ; Zou HQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):308-311. PubMed ID: 28377344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy.
    Shin DH; Lim BJ; Han IM; Han SG; Kwon YE; Park KS; Lee MJ; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Mod Pathol; 2016 Jul; 29(7):743-52. PubMed ID: 27102346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is complement factor H a susceptibility factor for IgA nephropathy?
    Edey M; Strain L; Ward R; Ahmed S; Thomas T; Goodship TH
    Mol Immunol; 2009 Apr; 46(7):1405-8. PubMed ID: 19162324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
    Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of mesangial C3 and C4d deposition in IgA nephropathy.
    Nam KH; Joo YS; Lee C; Lee S; Kim J; Yun HR; Park JT; Chang TI; Ryu DR; Yoo TH; Chin HJ; Kang SW; Jeong HJ; Lim BJ; Han SH;
    Clin Immunol; 2020 Feb; 211():108331. PubMed ID: 31899330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.